Baili Tianheng (688506.SH) issued a forecast loss. The net loss for 2023 is expected to be about 730 million yuan, and the loss will expand

According to the Zhitong Finance App, Baili Tianheng (688506.SH) released its 2023 annual performance forecast. The company expects to achieve a net loss of about 730 million yuan and an increase in losses in 2023; net loss attributable to the owner of the parent company after deducting non-recurring profit and loss is about 760 million yuan, and the loss will expand.

During the reporting period, the company continued to steadily advance research and development of innovative biopharmaceuticals, leading to a sharp year-on-year increase in R&D investment; during the reporting period, due to changes in market demand and national and local collection, sales and prices of some of the company's products declined, leading to a decline in revenue; during the reporting period, prices of Chinese herbal medicines and some packaging materials rose due to the impact of raw material market conditions.